Scotty Bowman, President

Over the course of a 35-year career, Scotty has amassed considerable pharma knowledge, including expertise in biotech, medical device, channel management, and government reporting. Prior to joining Occam, he held key leadership roles at Shire, most recently as SVP, US Market Access. At Shire, he was responsible for a $15B the entire portfolio market access strategy, specialty distribution design and contracting, government price reporting, 3PL management, government affairs and policy, strategic contracting with both public and private payers, and HUB service contracting and design.
Scotty is a member of the National Association Boards of Pharmacy, and recipient of the 2003 Henry Cade Industry Award.
Scotty has experience in many therapeutic areas, including anti-TNFs, infused antibiotics, enzyme replacement therapy, gastroenterology, Gaucher disease, growth hormone, HIV, hemophilia, hereditary angioedema, lysosomal storage disorder, oncology, primary immunodeficiencies, multiple CNS TAs, pulmonology and urology.
He also has delivery system coding expertise in device, patch, oral, infusion, SC, injectables, cellular tissue andgene therapy.